Therapeutic Asset Ratings
414 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Cdx-585
Colorectal Cancer
Celldex Therapeutics
P1
C
(39)
Cnsi-Fe
Colorectal Cancer
Sichuan Enray Pharmaceutical Sciences Company
P1
C
(39)
Cue-102
Colorectal Cancer
Cue Biopharma
P1
C
(39)
FLUDEOXYGLUCOSE
Colorectal Cancer
Peking University Cancer Hospital & Institute
P1
C
(39)
Fmpv-1
Colorectal Cancer
Hubro Therapeutics AS
P1
C
(39)
Migoprotafib
Colorectal Cancer
Genentech, Inc.
P1
C
(39)
Oxycodone
Colorectal Cancer
Fudan University
P1
C
(39)
Xmab808
Colorectal Cancer
Xencor, Inc.
P1
C
(39)
[111in]-fpi-2058
Colorectal Cancer
3B Pharmaceuticals GmbH
P1
C
(36)
177lu-dfc413
Colorectal Cancer
Novartis Pharmaceuticals
P1
C
(36)
[177Lu]Lu-A9-0631
Colorectal Cancer
Alpha-9 Oncology USA Inc.
P1
C
(36)
[177lu]lu-nns309
Colorectal Cancer
Novartis Pharmaceuticals
P1
C
(36)
[225Ac]Ac-A9-0642
Colorectal Cancer
Alpha-9 Oncology USA Inc.
P1
C
(36)
[225]-fpi-2059
Colorectal Cancer
3B Pharmaceuticals GmbH
P1
C
(36)
[68Ga]Ga-NNS309
Colorectal Cancer
Novartis Pharmaceuticals
P1
C
(36)
68Ga-NNS309
Colorectal Cancer
Novartis Pharmaceuticals
P1
C
(36)
Abbv-400
Colorectal Cancer
AbbVie
P1
C
(36)
ad5.f35-hgucy2c-padre vaccine
Colorectal Cancer
Thomas Jefferson University
P1
C
(36)
agx101
Colorectal Cancer
Angiex, Inc.
P1
C
(36)
ai-061
Colorectal Cancer
OncoC4, Inc.
P1
C
(36)
Anlotinib Hydrochloride Capsules
Colorectal Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
P1
C
(36)
Anti-Cea Car-T Cells
Colorectal Cancer
Changhai Hospital
P1
C
(36)
asp5834
Colorectal Cancer
Astellas Pharma Inc
P1
C
(36)
atp128
Colorectal Cancer
Amal Therapeutics
P1
C
(36)
ava6103
Colorectal Cancer
Avacta Life Sciences Ltd
P1
C
(36)
Showing 251 to 275 of 414 assets
Previous
Page 11 of 17
Next